Loading...
•
Dec 31, 2022
Mersana Q4 2022 Earnings Report
Mersana reported financial results and business update for Q4 2022.
Key Takeaways
Mersana Therapeutics reported their Q4 and Full Year 2022 financial results, highlighting advancements in their lead product candidate UpRi, diversification of their clinical pipeline, new collaborations, and a strengthened financial position.
Advanced UpRi in multiple clinical trials.
Diversified clinical pipeline.
Entered significant new collaborations.
Strengthened financial position.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...